U.S. flag An official website of the United States government
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: August 14-20, 2022
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: August 14-20, 2022

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner of Food and Drugs

Event Date: 08/15/2022
Location: Virtual
Subject: Infant Formula Issues
FDA Participant/Group: TRISTAN COLONIUS; MARK RAZA; FRANK YIANNAS; COURTNEY BUCHANAN; REBECCA BUCKNER;
Non FDA Participant/Group: Daniel Salvadori, Monica Wilkins, Robert Ford (Abbott Laboratories);

Event Date: 08/16/2022
Location: Silver Spring, MD
Subject: Supporting FDA
FDA Participant/Group: DAYLE CRISTINZIO; EMILY HELMS WILLIAMS; COURTNEY BUCHANAN; PHILIPA FRIEDMAN; STEPHANIE SOCGFACK;
Non FDA Participant/Group: Richard Schilsky, Susan Winckler (Reagan Udall Foundation);

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Andi Lipstein Fristedt, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

Event Date: 08/18/2022
Location: Quito, Ecuador
Subject: Confidentiality Commitment Signing Ceremony
FDA Participant/Group: KATHERINE SERRANO;
Non FDA Participant/Group: Andres Arens (Ministry of Fisheries and Aquaculture);

Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Erica Jefferson, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 08/15/2022
Location: Cambridge, MD
Subject: 26th Annual Good Manufacturing Practice (GMP) By The Sea Conference; CBER Update and Question and Answer Sessions
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, regulatory organizations, and other stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

Event Date: 08/16/2022
Location: Virtual
Subject: Digital Age Verification and TruAge™ Technology Meeting
FDA Participant/Group: THERESA MCDONALD; BEAZA YEHEYES; BRIAN KING; ESHAEL JOHNSON; DAVID OLIVEIRA; ELISE RICHMAN;
Non FDA Participant/Group: Doug Kantor, Lyle Beckwith (National Association of Convenience Stores (NACS)); Kyle McKeen (TruAge);

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Acting Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 
Back to Top